Intra-Cellular Therapies, Inc. Quarterly Return On Equity in % from Q4 2013 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Intra-Cellular Therapies, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2013 to Q2 2024.
  • Intra-Cellular Therapies, Inc. Return On Equity for the quarter ending June 30, 2024 was -11.5 %, a 59.9% increase year-over-year.
  • Intra-Cellular Therapies, Inc. annual Return On Equity for 2023 was -23 %, a 35.8% increase from 2022.
  • Intra-Cellular Therapies, Inc. annual Return On Equity for 2022 was -35.9 %, a 34.6% increase from 2021.
  • Intra-Cellular Therapies, Inc. annual Return On Equity for 2021 was -54.9 %, a 31.6% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -11.5 +17.1 +59.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -18.5 +15.4 +45.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -23 +12.9 +35.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -24.9 +20.6 +45.3% Jul 1, 2023 Sep 30, 2023
Q2 2023 -28.6 +24.5 +46.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 -33.9 +20 +37.1% Jan 1, 2023 Mar 31, 2023
Q4 2022 -35.9 +19 +34.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -45.5 -0.64 -1.43% Jul 1, 2022 Sep 30, 2022
Q2 2022 -53.1 -15.6 -41.7% Apr 1, 2022 Jun 30, 2022
Q1 2022 -53.9 -14.5 -36.8% Jan 1, 2022 Mar 31, 2022
Q4 2021 -54.9 -13.2 -31.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 -44.9 +3.39 +7.02% Jul 1, 2021 Sep 30, 2021
Q2 2021 -37.5 +23.1 +38.1% Apr 1, 2021 Jun 30, 2021
Q1 2021 -39.4 +18.4 +31.8% Jan 1, 2021 Mar 31, 2021
Q4 2020 -41.7 +19.4 +31.7% Oct 1, 2020 Dec 31, 2020
Q3 2020 -48.3 +6 +11.1% Jul 1, 2020 Sep 30, 2020
Q2 2020 -60.6 -9.77 -19.2% Apr 1, 2020 Jun 30, 2020
Q1 2020 -57.8 -12.1 -26.3% Jan 1, 2020 Mar 31, 2020
Q4 2019 -61.1 -19.3 -46.2% Oct 1, 2019 Dec 31, 2019
Q3 2019 -54.3 -18.6 -52.2% Jul 1, 2019 Sep 30, 2019
Q2 2019 -50.8 -19.1 -60.1% Apr 1, 2019 Jun 30, 2019
Q1 2019 -45.8 -18.1 -65.4% Jan 1, 2019 Mar 31, 2019
Q4 2018 -41.8 -15.1 -56.7% Oct 1, 2018 Dec 31, 2018
Q3 2018 -35.7 -8.27 -30.2% Jul 1, 2018 Sep 30, 2018
Q2 2018 -31.7 -3.81 -13.6% Apr 1, 2018 Jun 30, 2018
Q1 2018 -27.7 +2.06 +6.93% Jan 1, 2018 Mar 31, 2018
Q4 2017 -26.7 +1.5 +5.33% Oct 1, 2017 Dec 31, 2017
Q3 2017 -27.4 -0.54 -2.01% Jul 1, 2017 Sep 30, 2017
Q2 2017 -27.9 -2.14 -8.3% Apr 1, 2017 Jun 30, 2017
Q1 2017 -29.7 -2.73 -10.1% Jan 1, 2017 Mar 31, 2017
Q4 2016 -28.2 +1.69 +5.66% Oct 1, 2016 Dec 31, 2016
Q3 2016 -26.9 +7.93 +22.8% Jul 1, 2016 Sep 30, 2016
Q2 2016 -25.8 +12.7 +33% Apr 1, 2016 Jun 30, 2016
Q1 2016 -27 +4.47 +14.2% Jan 1, 2016 Mar 31, 2016
Q4 2015 -29.9 -6.95 -30.3% Oct 1, 2015 Dec 31, 2015
Q3 2015 -34.8 -13.7 -65.1% Jul 1, 2015 Sep 30, 2015
Q2 2015 -38.5 -13.5 -53.8% Apr 1, 2015 Jun 30, 2015
Q1 2015 -31.5 +16.7 +34.7% Jan 1, 2015 Mar 31, 2015
Q4 2014 -22.9 +128 +84.8% Oct 1, 2014 Dec 31, 2014
Q3 2014 -21.1 Jul 1, 2014 Sep 30, 2014
Q2 2014 -25 Apr 1, 2014 Jun 30, 2014
Q1 2014 -48.2 Jan 1, 2014 Mar 31, 2014
Q4 2013 -151 Oct 1, 2013 Dec 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.